58 related articles for article (PubMed ID: 28132057)
1. Is Beta-Blocker Use Beneficial in Breast Cancer? A Meta-Analysis.
Kim HY; Jung YJ; Lee SH; Jung HJ; Pak K
Oncology; 2017; 92(5):264-268. PubMed ID: 28132057
[TBL] [Abstract][Full Text] [Related]
2. Beta-blocker drug therapy reduces secondary cancer formation in breast cancer and improves cancer specific survival.
Powe DG; Voss MJ; Zänker KS; Habashy HO; Green AR; Ellis IO; Entschladen F
Oncotarget; 2010 Nov; 1(7):628-638. PubMed ID: 21317458
[TBL] [Abstract][Full Text] [Related]
3. Propranolol and survival from breast cancer: a pooled analysis of European breast cancer cohorts.
Cardwell CR; Pottegård A; Vaes E; Garmo H; Murray LJ; Brown C; Vissers PA; O'Rorke M; Visvanathan K; Cronin-Fenton D; De Schutter H; Lambe M; Powe DG; van Herk-Sukel MP; Gavin A; Friis S; Sharp L; Bennett K
Breast Cancer Res; 2016 Dec; 18(1):119. PubMed ID: 27906047
[TBL] [Abstract][Full Text] [Related]
4. Beta-adrenergic signaling, a novel target for cancer therapy?
Schuller HM
Oncotarget; 2010 Nov; 1(7):466-469. PubMed ID: 21317444
[No Abstract] [Full Text] [Related]
5. Effect of beta-blockers on cancer recurrence and survival: a meta-analysis of epidemiological and perioperative studies.
Yap A; Lopez-Olivo MA; Dubowitz J; Pratt G; Hiller J; Gottumukkala V; Sloan E; Riedel B; Schier R
Br J Anaesth; 2018 Jul; 121(1):45-57. PubMed ID: 29935594
[TBL] [Abstract][Full Text] [Related]
6. Concurrent new drug prescriptions and prognosis of early breast cancer: studies using the Danish Breast Cancer Group clinical database.
Cronin-Fenton D; Lash TL; Ahern TP; Damkier P; Christiansen P; Ejlertsen B; Sørensen HT
Acta Oncol; 2018 Jan; 57(1):120-128. PubMed ID: 29202630
[TBL] [Abstract][Full Text] [Related]
7. Beta blockade as adjunctive breast cancer therapy: A review.
Phadke S; Clamon G
Crit Rev Oncol Hematol; 2019 Jun; 138():173-177. PubMed ID: 31092374
[TBL] [Abstract][Full Text] [Related]
8. The beta adrenergic receptor antagonist propranolol alters mitogenic and apoptotic signaling in late stage breast cancer.
Montoya A; Varela-Ramirez A; Dickerson E; Pasquier E; Torabi A; Aguilera R; Nahleh Z; Bryan B
Biomed J; 2019 Jun; 42(3):155-165. PubMed ID: 31466709
[TBL] [Abstract][Full Text] [Related]
9. β-Blocker use is not associated with improved clinical outcomes in women with breast cancer: a meta-analysis.
Li C; Li T; Tang R; Yuan S; Zhang W
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32436935
[TBL] [Abstract][Full Text] [Related]
10. Association between perioperative beta blocker use and cancer survival following surgical resection.
Musselman RP; Bennett S; Li W; Mamdani M; Gomes T; van Walraven C; Boushey R; Al-Obeed O; Al-Omran M; Auer RC
Eur J Surg Oncol; 2018 Aug; 44(8):1164-1169. PubMed ID: 29858097
[TBL] [Abstract][Full Text] [Related]
11. ß-Adrenoreceptors in Human Cancers.
Kraboth Z; Kalman B
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835082
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer and neurotransmitters: emerging insights on mechanisms and therapeutic directions.
Jayachandran P; Battaglin F; Strelez C; Lenz A; Algaze S; Soni S; Lo JH; Yang Y; Millstein J; Zhang W; Shih JC; Lu J; Mumenthaler SM; Spicer D; Neman J; Roussos Torres ET; Lenz HJ
Oncogene; 2023 Feb; 42(9):627-637. PubMed ID: 36650218
[TBL] [Abstract][Full Text] [Related]
13. Screening of GPCR drugs for repurposing in breast cancer.
Abdulkareem NM; Bhat R; Powell RT; Chikermane S; Yande S; Trinh L; Abdelnasser HY; Tabassum M; Ruiz A; Sobieski M; Nguyen ND; Park JH; Johnson CA; Kaipparettu BA; Bond RA; Johnson M; Stephan C; Trivedi MV
Front Pharmacol; 2022; 13():1049640. PubMed ID: 36561339
[TBL] [Abstract][Full Text] [Related]
14. Obesity and cancer-extracellular matrix, angiogenesis, and adrenergic signaling as unusual suspects linking the two diseases.
Pellegata NS; Berriel Diaz M; Rohm M; Herzig S
Cancer Metastasis Rev; 2022 Sep; 41(3):517-547. PubMed ID: 36074318
[TBL] [Abstract][Full Text] [Related]
15. Breast Cancer and Anaesthesia: Genetic Influence.
Raigon Ponferrada A; Guerrero Orriach JL; Molina Ruiz JC; Romero Molina S; Gómez Luque A; Cruz Mañas J
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299272
[TBL] [Abstract][Full Text] [Related]
16. A narrative review on the interaction between genes and the treatment of hypertension and breast cancer.
Wang W; He Q; Zhang H; Zhuang C; Wang Q; Li C; Sun R; Fan X; Yu J
Ann Transl Med; 2021 May; 9(10):894. PubMed ID: 34164528
[TBL] [Abstract][Full Text] [Related]
17. Cardioprotective medication use in Black and white breast cancer survivors.
Sutton AL; Felix AS; Bandyopadhyay D; Retnam R; Hundley WG; Sheppard VB
Breast Cancer Res Treat; 2021 Aug; 188(3):769-778. PubMed ID: 33797652
[TBL] [Abstract][Full Text] [Related]
18. Beta-blockers in early-stage breast cancer: a systematic review and meta-analysis.
Caparica R; Bruzzone M; Agostinetto E; De Angelis C; Fêde Â; Ceppi M; de Azambuja E
ESMO Open; 2021 Apr; 6(2):100066. PubMed ID: 33639601
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
